Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Dynavax Technologies (NQ: DVAX )

10.14 USD +0.18 (+1.81%)
Official Closing Price Updated: 7:52 PM EDT, Apr 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,467,500
Open 9.970
Bid (Size) 10.12 (2)
Ask (Size) 10.18 (2)
Prev. Close 9.960
Today's Range 9.930 - 10.56
52wk Range 3.000 - 12.44
Shares Outstanding 100,753,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Positive Phase 1/2 Results for Valneva's Inactivated COVID-19 Vaccine Candidate Using Dynavax's CpG 1018™ Adjuvant
- VLA2001, an inactivated COVID-19 vaccine candidate with CpG 1018 adjuvant, was highly immunogenic and generally safe and well tolerated 
From PR Newswire
Valneva Reports Positive Phase 1/2 Data for Its Inactivated, Adjuvanted COVID-19 Vaccine Candidate, VLA2001
From GlobeNewswire News Releases

Performance

YTD
+119.48%
+119.48%
1 Month
-0.69%
-0.69%
3 Month
+99.21%
+99.21%
6 Month
+120.92%
+120.92%
1 Year
+212.00%
+212.00%

More News

Read More
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
Effective Diagnostics Help to Tame the Spread of the Pandemic
From PR Newswire
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
From PR Newswire
Clover Biopharmaceuticals and Dynavax Announce First Participants Dosed in SPECTRA, a Global Phase 2/3 Clinical Trial for Adjuvanted S-Trimer COVID-19 Vaccine Candidate
From PR Newswire
COVID-19 Pandemic Still Fueling Need For Increased Supplies & New Technology In PPE Markets
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
COVID-19 Pandemic Still Fueling Need For Increased Supplies & New Technology In PPE Markets
From PR Newswire
Dynavax to Present at the H.C. Wainwright Virtual 2021 Global Life Sciences Conference
From PR Newswire
Dynavax Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From PR Newswire
Valneva's COVID-19 Vaccine Candidate Using Dynavax's Adjuvant Shows Positive Interim Results
Tags FDA Small Cap Market News
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.